Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19 is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0.464. It has been cited 9 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0.118
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
National Institutes of Health
Grant: 3U24TR001608-05S1
Admin Supplement - Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)
National Institutes of Health
Grant: 1UL1TR002345-01
Washington University Institute of Clinical and Translational Sciences
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals